Current management of disseminated intravascular coagulation.
Disseminated intravascular coagulation is a complex process seen in a wide variety of clinical disorders. The oncology patient may develop this syndrome either as a result of the neoplasm itself or of the treatment of the neoplasm. An understanding of the pathophysiology of disseminated intravascular coagulation is essential for diagnosis and treatment. Diagnosis is accomplished by correlating clinical and laboratory data. Treatment remains controversial, but reversal of the triggering mechanism is the single most important factor in successful treatment. Other interventions, including the use of heparin, antithrombin III, and hirudin, are being studied. Much remains to be understood about disseminated intravascular coagulation, and controlled clinical trials are needed to define optimal treatment.
Wheeler
A
A
Department of Medical Specialties, University of Texas, M.D. Anderson Cancer Center, Houston.
Rubenstein
E B
EB
D000990:Antithrombin III / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006493:Heparin / Q000627:therapeutic use; D024764:Hirudin Therapy; D006801:Humans
D000990:Antithrombin III; D006493:Heparin